{"assetProfile": {"address1": "700 Saginaw Drive", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 481 6801", "website": "https://www.revmed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.", "fullTimeEmployees": 700, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark A. Goldsmith M.D., Ph.D.", "age": 62, "title": "CEO, President & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": {"raw": 1347967, "fmt": "1.35M", "longFmt": "1,347,967"}, "exercisedValue": {"raw": 10163472, "fmt": "10.16M", "longFmt": "10,163,472"}, "unexercisedValue": {"raw": 51843852, "fmt": "51.84M", "longFmt": "51,843,852"}}, {"maxAge": 1, "name": "Mr. Jack  Anders", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": {"raw": 725633, "fmt": "725.63k", "longFmt": "725,633"}, "exercisedValue": {"raw": 849639, "fmt": "849.64k", "longFmt": "849,639"}, "unexercisedValue": {"raw": 2896538, "fmt": "2.9M", "longFmt": "2,896,538"}}, {"maxAge": 1, "name": "Ms. Margaret A. Horn J.D.", "age": 61, "title": "Chief Operating Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": {"raw": 897933, "fmt": "897.93k", "longFmt": "897,933"}, "exercisedValue": {"raw": 3021392, "fmt": "3.02M", "longFmt": "3,021,392"}, "unexercisedValue": {"raw": 16625696, "fmt": "16.63M", "longFmt": "16,625,696"}}, {"maxAge": 1, "name": "Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.", "age": 63, "title": "President of Research & Development", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": {"raw": 951933, "fmt": "951.93k", "longFmt": "951,933"}, "exercisedValue": {"raw": 4257259, "fmt": "4.26M", "longFmt": "4,257,259"}, "unexercisedValue": {"raw": 11511893, "fmt": "11.51M", "longFmt": "11,511,893"}}, {"maxAge": 1, "name": "Ms. Xiaolin  Wang", "age": 54, "title": "Executive Vice President of Development", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": {"raw": 701200, "fmt": "701.2k", "longFmt": "701,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 13540803, "fmt": "13.54M", "longFmt": "13,540,803"}}, {"maxAge": 1, "name": "Dr. Martin D. Burke M.D., Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael A. Fischbach Ph.D.", "age": 43, "title": "Academic Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kevan M. Shokat Ph.D.", "title": "Academic Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Walter  Reiher Ph.D.", "title": "Chief Information Officer", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jan  Smith Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [], "earningsCallDate": [], "earningsAverage": {}, "earningsLow": {}, "earningsHigh": {}, "revenueAverage": {"raw": 1581250, "fmt": "1.58M", "longFmt": "1,581,250"}, "revenueLow": {"raw": 0, "fmt": null, "longFmt": "0"}, "revenueHigh": {"raw": 20800000, "fmt": "20.8M", "longFmt": "20,800,000"}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-09-30", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 1581250, "fmt": "1.58M", "longFmt": "1,581,250"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 20800000, "fmt": "20.8M", "longFmt": "20,800,000"}, "numberOfAnalysts": {"raw": 16, "fmt": "16", "longFmt": "16"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "+1q", "endDate": "2025-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 1581250, "fmt": "1.58M", "longFmt": "1,581,250"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 20800000, "fmt": "20.8M", "longFmt": "20,800,000"}, "numberOfAnalysts": {"raw": 16, "fmt": "16", "longFmt": "16"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 3168750, "fmt": "3.17M", "longFmt": "3,168,750"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 41700000, "fmt": "41.7M", "longFmt": "41,700,000"}, "numberOfAnalysts": {"raw": 16, "fmt": "16", "longFmt": "16"}, "yearAgoRevenue": {"raw": 0, "fmt": null, "longFmt": "0"}, "growth": {"raw": 0.0, "fmt": "0.00%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 27662670, "fmt": "27.66M", "longFmt": "27,662,670"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 174700000, "fmt": "174.7M", "longFmt": "174,700,000"}, "numberOfAnalysts": {"raw": 15, "fmt": "15", "longFmt": "15"}, "yearAgoRevenue": {"raw": 3168750, "fmt": "3.17M", "longFmt": "3,168,750"}, "growth": {"raw": 7.7297997, "fmt": "772.98%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 0.3642, "fmt": "0.36"}, "targetHighPrice": {}, "targetLowPrice": {}, "targetMeanPrice": {}, "targetMedianPrice": {}, "recommendationMean": {}, "recommendationKey": "none", "numberOfAnalystOpinions": {}, "totalCash": {"raw": 2137170944, "fmt": "2.14B", "longFmt": "2,137,170,944"}, "totalCashPerShare": {"raw": 11.433, "fmt": "11.43"}, "ebitda": {"raw": -890700032, "fmt": "-890.7M", "longFmt": "-890,700,032"}, "totalDebt": {"raw": 132787000, "fmt": "132.79M", "longFmt": "132,787,000"}, "quickRatio": {"raw": 11.581, "fmt": "11.58"}, "currentRatio": {"raw": 11.794, "fmt": "11.79"}, "totalRevenue": {}, "debtToEquity": {"raw": 7.119, "fmt": "7.12%"}, "revenuePerShare": {}, "returnOnAssets": {"raw": -0.26472, "fmt": "-26.47%"}, "returnOnEquity": {"raw": -0.46613997, "fmt": "-46.61%"}, "grossProfits": {"raw": -604710016, "fmt": "-604.71M", "longFmt": "-604,710,016"}, "freeCashflow": {"raw": -396289984, "fmt": "-396.29M", "longFmt": "-396,289,984"}, "operatingCashflow": {"raw": -684900992, "fmt": "-684.9M", "longFmt": "-684,900,992"}, "earningsGrowth": {}, "revenueGrowth": {}, "grossMargins": {"raw": 0.0, "fmt": "0.00%"}, "ebitdaMargins": {"raw": 0.0, "fmt": "0.00%"}, "operatingMargins": {"raw": 0.0, "fmt": "0.00%"}, "profitMargins": {"raw": 0.0, "fmt": "0.00%"}, "financialCurrency": "USD"}}